Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review

by Hong-Bo Li, Zi-Han Yang, Qing-Qu Guo
Published 2021

Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location

by Min Kyu Sung, Yejong Park, Bong Jun Kwak, Eunsung Jun, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Song Cheol Kim
Published 2021

Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway

by Rong-Jane Chen, Yi-Jhen Lyu, Yu-Ying Chen, Yen-Chien Lee, Min-Hsiung Pan, Yuan-Soon Ho, Ying-Jan Wang
Published 2021

CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid‐derived suppressor cells

by Haitao Gu, Wensheng Deng, Zhong Zheng, Ke Wu, Feng Sun
Published 2021

Identification of Hub Genes in Pancreatic Ductal Adenocarci-noma Using Bioinformatics Analysis

by Congcong Wang, Jianping Guo, Xiaoyang Zhao, Jia Jia, Wenting Xu, Peng Wan, Changgang Sun
Published 2021

Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment

by Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA
Published 2021

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance

by Antonia Malinova, Lisa Veghini, Francisco X. Real, Francisco X. Real, Francisco X. Real, Vincenzo Corbo, Vincenzo Corbo
Published 2021

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine

by Federica Vernuccio, Carlo Messina, Valeria Merz, Roberto Cannella, Massimo Midiri
Published 2021

Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer

by Courtney T. Stump, Kevin Roehle, Nataly Manjarrez Orduno, Stephanie K. Dougan
Published 2021

Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

by Shiwei Guo, Hao Qin, Ke Liu, Huan Wang, Sijia Bai, Shiyi Liu, Zhuo Shao, Yanan Zhang, Bin Song, Xiaoya Xu, Jing Shen, Peng Zeng, Xiaohan Shi, Hao Chen, Suizhi Gao, Jiajia Xu, Yaqi Pan, Lei Xiong, Fugen Li, Dadong Zhang, Xiaodong Jiao, Gang Jin
Published 2021

Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma

by Cheng-Wei Chou, Yu-Hsiu Hsieh, Su-Chi Ku, Wan-Jou Shen, Gangga Anuraga, Hoang Dang Khoa Ta, Kuen-Haur Lee, Yu-Cheng Lee, Cheng-Hsien Lin, Chih-Yang Wang, Wei-Jan Wang
Published 2021

Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits

by Parniyan Maneshi, Parniyan Maneshi, James Mason, James Mason, Mitesh Dongre, Mitesh Dongre, Daniel Öhlund, Daniel Öhlund
Published 2021

Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer

by Lu T, Prakash J
Published 2021

High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma

by Dong-jin Wu, Yong-sheng Jiang, Rui-zhe He, Ling-ye Tao, Min-wei Yang, Xue-liang Fu, Jiang-yu Yang, Kun Zhu
Published 2018

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma

by Jinsheng Ding, Jinsheng Ding, Jinsheng Ding, Hui Li, Hui Li, Yang Liu, Yang Liu, Yongjie Xie, Yongjie Xie, Jie Yu, Huizhi Sun, Huizhi Sun, Di Xiao, Yizhang Zhou, Li Bao, Hongwei Wang, Chuntao Gao
Published 2021

Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples

by Emmy Borgmästars, Erik Lundberg, Daniel Öhlund, Hanna Nyström, Oskar Franklin, Christina Lundin, Pär Jonsson, Malin Sund
Published 2021

Discovery of GOT1 Inhibitors from a Marine-Derived <i>Aspergillus terreus</i> That Act against Pancreatic Ductal Adenocarcinoma

by Shan Yan, Changxing Qi, Wei Song, Qianqian Xu, Lianghu Gu, Weiguang Sun, Yonghui Zhang
Published 2021

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma

by Farnaz Sedigheh Takhsha, Christel Vangestel, Christel Vangestel, Muhammet Tanc, Muhammet Tanc, Sven De Bruycker, Sven De Bruycker, Maya Berg, Isabel Pintelon, Sigrid Stroobants, Sigrid Stroobants, Guido R. Y. De Meyer, Guido R. Y. De Meyer, Pieter Van Der Veken, Pieter Van Der Veken, Wim Martinet, Wim Martinet
Published 2021

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma

by Iranzu González-Borja, Emilia Alors-Pérez, Emilia Alors-Pérez, Emilia Alors-Pérez, Emilia Alors-Pérez, Irene Amat, Laura Alonso, Cristina Viyuela-García, Cristina Viyuela-García, Cristina Viyuela-García, Saioa Goñi, José C. Reyes, María Ceballos-Chávez, Irene Hernández-García, Marina E. Sánchez-Frías, Marina E. Sánchez-Frías, Marina E. Sánchez-Frías, Enrique Santamaría, Socorro Razquin, Álvaro Arjona-Sánchez, Álvaro Arjona-Sánchez, Álvaro Arjona-Sánchez, Virginia Arrazubi, Jairo Pérez-Sanz, Ruth Vera, Joaquín Fernández-Irigoyen, Justo P. Castaño, Justo P. Castaño, Justo P. Castaño, Justo P. Castaño, Antonio Viúdez, Antonio Viúdez, Antonio Viúdez
Published 2021

Advances in Pancreatic Ductal Adenocarcinoma Treatment

by Eric M. Anderson, Shant Thomassian, Jun Gong, Andrew Hendifar, Arsen Osipov
Published 2021